Bausch & Lomb BLCO
NYSE BLCO
$17.24 +0.04 (+0.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch & Lomb (BLCO) Other Non-Current Liabilities (2021 - 2026)

Bausch & Lomb's (BLCO) quarterly Other Non-Current Liabilities came in at $435.0 million in Q2 2026, up 353.12% YoY from $96.0 million in Q2 2025, and down 5.02% on a QoQ basis from $458.0 million in Q1 2026.

Bausch & Lomb (BLCO) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has 6 years of Other Non-Current Liabilities data on file, last reported at $435.0 million in Q2 2026.

  • Quarterly Other Non-Current Liabilities rose 353.12% year-over-year to $435.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $435.0 million (up 353.12% YoY) and the FY2025 annual result came in at $521.0 million, up 21.16% from the prior year.
  • Other Non-Current Liabilities slipped to $435.0 million in Q2 2026, from $458.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $521.0 million in Q4 2025 to a low of $4.0 million in Q2 2022.
  • A 5-year average of $194.1 million and a median of $71.0 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Other Non-Current Liabilities changed 0.0% — and 2025, when it jumped 986.96%.
  • Tracing BLCO's Other Non-Current Liabilities over 5 years: stood at $329.0 million in 2022, then climbed by 20.67% to $397.0 million in 2023, then advanced by 8.31% to $430.0 million in 2024, then rose by 21.16% to $521.0 million in 2025, then dropped by 16.51% to $435.0 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $435.0 million (Q2 2026), $458.0 million (Q1 2026), and $521.0 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Bausch & Lomb 6.14 Bn 5.76 Bn 867.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 435.00 Mn
Mar 31, 2026 458.00 Mn
Dec 31, 2025 521.00 Mn
Sep 30, 2025 500.00 Mn
Jun 30, 2025 96.00 Mn
Mar 31, 2025 114.00 Mn
Dec 31, 2024 430.00 Mn
Sep 30, 2024 46.00 Mn
Jun 30, 2024 44.00 Mn
Mar 31, 2024 45.00 Mn
Dec 31, 2023 397.00 Mn
Sep 30, 2023 42.00 Mn
Jun 30, 2023 10.00 Mn
Mar 31, 2023 9.00 Mn
Dec 31, 2022 329.00 Mn
Sep 30, 2022 4.00 Mn
Jun 30, 2022 4.00 Mn
Mar 31, 2022 9.00 Mn
Dec 31, 2021 298.00 Mn